Versant Capital Management’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
KCM
Versant Capital Management's LEGN Position: Q3 2026 in Review
Versant Capital Management increased its Legend Biotech (LEGN) stake by 1,435% in Q3 2026, buying an estimated $6.12K and bringing the position to 307 shares worth $6.11K. The position accounts for ﹤0.01% of the portfolio, ranked #2416.
Versant Capital Management first reported a position in LEGN in Q2 2026 and has held it in 2 quarters since. 197 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.
- Versant Capital Management held 307 shares of Legend Biotech worth $6.11K as of Q3 2026.
- Versant Capital Management bought 287 Legend Biotech shares in Q3 2026, an estimated $6.12K.
- Legend Biotech made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2416 holding.
- Versant Capital Management first reported a position in Legend Biotech in Q2 2026 and has held it in 2 quarters since.
- 197 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.